Literature DB >> 6414602

Adjuvant chemotherapy for early breast cancer.

.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6414602      PMCID： PMC1549349          DOI： 10.1136/bmj.287.6399.1141-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  10 in total

1.  Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.

Authors:  B Fisher; R G Ravdin; R K Ausman; N H Slack; G E Moore; R J Noer
Journal:  Ann Surg       Date:  1968-09       Impact factor: 12.969

2.  Complete remissions in metastatic breast cancer treated with combination drug therapy.

Authors:  S S Legha; A U Buzdar; T L Smith; G N Hortobagyi; K D Swenerton; G R Blumenschein; E A Gehan; G P Bodey; E J Freireich
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

3.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

4.  Adjuvant chemotherapy in breast cancer.

Authors:  R Nissen-Meyer; K Kjellgren; B Mansson
Journal:  Recent Results Cancer Res       Date:  1982

5.  Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis.

Authors:  D A Decker; D L Ahmann; H F Bisel; J H Edmonson; R G Hahn; J R O'Fallon
Journal:  JAMA       Date:  1979-11-09       Impact factor: 56.272

6.  A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.

Authors:  D C Tormey; V E Weinberg; J F Holland; R B Weiss; O J Glidewell; M Perloff; G Falkson; H C Falkson; P H Henry; L A Leone
Journal:  J Clin Oncol       Date:  1983-02       Impact factor: 44.544

7.  Prognostic factors in metastatic breast cancer treated with combination chemotherapy.

Authors:  K D Swenerton; S S Legha; T Smith; G N Hortobagyi; E A Gehan; H Y Yap; J U Gutterman; G R Blumenschein
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

8.  Controlled trial of adjuvant chemotherapy with melphalan for breast cancer.

Authors:  R D Rubens; J L Hayward; R K Knight; R D Bulbrook; I S Fentiman; M Chaudary; A Howell; H Bush; D Crowther; R A Sellwood; W D George; J M Howat
Journal:  Lancet       Date:  1983-04-16       Impact factor: 79.321

9.  Adjuvant chemotherapy of breast cancer.

Authors:  R G Cooper; J F Holland; O Glidewell
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

10.  Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trial.

Authors:  S E Jones; S E Salmon; H Allen; G F Giordano; S Davis; E Chase; T E Moon; R S Heusinkveld
Journal:  Recent Results Cancer Res       Date:  1982
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.